Redefining Breast Cancer Diagnostics
Transforming Breast Tissue Analysis
At Micrima, we are reimagining breast cancer diagnosis. We aim to empower clinicians and women with information and tools to help diagnose breast cancer earlier.
HOW DO WE DO THIS?
By providing measurements of breast tissue properties, we enable personalised imaging strategies and enhance risk profiling. We aim to improve outcomes and support proactive, informed decisions in women's healthcare and to ensure women are aware of their breast cancer risk.
Why is breast density so important?
Dense breast tissue can obscure cancer on a mammogram. Breast cancer risk increases as breast density increases.
MAKING BREAST DENSITY DATA ACCESSIBLE
Discover the new standard for breast tissue analysis
Image displaying increasing breast density Courtesy of Matt Covington, MD and My Density Matters
BREAST DENSITY SHOULDN’T BE A MYSTERY
The problem.
The solution.
Dense breasts are common and normal but reduce mammogram sensitivity. Currently, density can only be measured through a mammogram and women are not informed about their density after the scan.
This makes vital density data lengthy to obtain for healthcare professionals and makes it inaccessible for younger women, which lowers cancer detection rates and leaves women in the dark regarding their breast cancer risk.
A new breast tissue analysis method that quickly and safely provides breast density data, enabling personalised imaging and instant risk assessment for all women.
“What you’re developing is a new concept, and to be honest with you, that’s what we need because we can’t deliver using the current concept.”
- Dr Nisha Sharma, Clinical Lead, Leeds NHS Foundation Trust Breast Services and Chair of the Micrima Clinical Advisory Board